The Platform Group AG Increases 2026 Forecast Amidst Strategic Acquisitions

The Platform Group AG, headquartered in Düsseldorf, has revised its 2026 financial forecast. The company now expects sales of EUR 1 billion and an EBITDA between EUR 70 to 80 million, up from previous forecasts of EUR 860 million in sales and over EUR 64 million in EBITDA. Additionally, its GMV is anticipated to reach EUR 1.7 billion.

This upward revision is attributed primarily to strategic acquisitions in the pharmaceutical sector. The group has acquired a majority stake in Apothekia GmbH and maintains a 50% stake in the Contracta Group. Alongside its expansions, the "Service & Retail Goods" segment will be rebranded as "Pharma & Service Goods".

Further, the company plans two additional acquisitions in the Optics & Hearing sector, aiming to close these deals by the end of 2025, pending regulatory approvals.